Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Straub

Showing results (281-290 of 374) with videos related to

Pageof 38
Sort By:
Scientific Reports|November 29, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpointLaurent Servais, Paul Strijbos, Margaux Poleur, et al.
Journal of Neurology|May 26, 2026
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2Carla F Bolano-Diaz, Jose Verdu-Diaz, Dan Hao, et al.
Neuromuscular Disorders : NMD|March 27, 2023
Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI patternLaura Llansó, Ursula Moore, Carla Bolano-Diaz, et al.
Journal of Neurology|January 15, 2025
Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathyPablo Iruzubieta, José Verdú-Díaz, Ana Töpf, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
European Journal of Neurology|March 14, 2021
Deep phenotyping of an international series of patients with late-onset dysferlinopathyGorka Fernández-Eulate, Giorgia Querin, Ursula Moore, et al.
Journal of Neurology|August 16, 2025
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trialPriya S Kishnani, Jordi Díaz-Manera, Sergey Illarioshkin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2026
Respiratory function in Becker muscular dystrophy: a comprehensive longitudinal studyPietro Riguzzi, Emma Grover, Marianela Schiava, et al.
Brain : a Journal of Neurology|September 13, 2021
Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophyJorge Alonso-Pérez, Lidia González-Quereda, Claudio Bruno, et al.
Journal of Neurology|June 7, 2025
Characterisation of a large, single-centre cohort of patients with Becker muscular dystrophy to inform standardised care guidelinesPietro Riguzzi, Holly Borland, Meredith K James, et al.
Pageof 38

Showing results (281-290 of 374) with videos related to

Sort By:
Pageof 38
Scientific Reports|November 29, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpointLaurent Servais, Paul Strijbos, Margaux Poleur, et al.
Journal of Neurology|May 26, 2026
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2Carla F Bolano-Diaz, Jose Verdu-Diaz, Dan Hao, et al.
Neuromuscular Disorders : NMD|March 27, 2023
Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI patternLaura Llansó, Ursula Moore, Carla Bolano-Diaz, et al.
Journal of Neurology|January 15, 2025
Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathyPablo Iruzubieta, José Verdú-Díaz, Ana Töpf, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
European Journal of Neurology|March 14, 2021
Deep phenotyping of an international series of patients with late-onset dysferlinopathyGorka Fernández-Eulate, Giorgia Querin, Ursula Moore, et al.
Journal of Neurology|August 16, 2025
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trialPriya S Kishnani, Jordi Díaz-Manera, Sergey Illarioshkin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2026
Respiratory function in Becker muscular dystrophy: a comprehensive longitudinal studyPietro Riguzzi, Emma Grover, Marianela Schiava, et al.
Brain : a Journal of Neurology|September 13, 2021
Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophyJorge Alonso-Pérez, Lidia González-Quereda, Claudio Bruno, et al.
Journal of Neurology|June 7, 2025
Characterisation of a large, single-centre cohort of patients with Becker muscular dystrophy to inform standardised care guidelinesPietro Riguzzi, Holly Borland, Meredith K James, et al.
Pageof 38